MTOR and cancer: This research area stems from pioneering work showing that the systemic hyperinsulinemia observed in cancer patients treated with a PI3K inhibitor, which is able to reactivate mTOR signaling in cancer cells, can be blocked by a ketogenic diet, allowing more effective control of tumor growth than PI3K inhibitor treatment alone (177).